ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Lung cancer

Mastering Robotic Lung Resection: The French Lobectomy Technique for Standardized Surgical Education
July 8, 2025
This video demonstrates a standardized robotic segmentectomy using the French lobectomy technique, structured in five anatomical zones. It highlights the integration of 3D reconstruction and mixed reality planning in the surgical management of a left basal pyramid lesion in a 76-year-old patient.
The Impact of Preoperative Invasive Nodal Staging on Unexpected Mediastinal Upstaging in Early-Stage Non-small Cell Lung Cancer
June 26, 2025
This study evaluated the effect of perioperative invasive nodal staging on nodal upstaging in early-stage non-small cell lung cancer (NSCLC) patients undergoing resection.
Augmented Reality–Assisted Robotic Segmentectomy Using Open-Source Tools: A Practical and Low-Cost Solution
June 24, 2025
This video demonstrates a low-cost method for implementing augmented reality in robotic segmentectomy using open-source software and affordable hardware.
Lymph Node Sampling and Survival in Non-Small Cell Lung Cancer: A 10-Year Danish Cohort Study
May 22, 2025
This retrospective study examined whether following intraoperative lymph node sampling guidelines influenced overall survival and nodal upstaging in patients with non-small cell lung cancer (NSCLC) who underwent lung resection in Denmark from 2012 to 2021.
Pleural Invasion of Peripheral cT1 Lung Cancer by Deep Learning Analysis of Thoracoscopic Images: A Retrospective Pilot Study
May 22, 2025
This research developed a deep learning algorithm to predict pathological pleural invasion (pPL) from thoracoscopic imagery in patients with cT1 tumors receiving sublobar resections. The study included 80 patients, with the learning model trained on 64 cases and validated on 16.
Extended Sleeve Lobectomy After Neoadjuvant Immunochemotherapy for Centrally Located Non-Small Cell Lung Cancer
May 1, 2025
Extended sleeve lobectomy (ESL) is considered a lung-sparing alternative to pneumonectomy (PN) for centrally located non-small cell lung cancer (NSCLC) when standard sleeve lobectomy (SSL) is not feasible. This retrospective study analyzed 94 patients who received neoadjuvant immunochemotherapy followed by either PN, ESL, or SSL.
Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)
May 1, 2025
The recent CheckMate 816 trial indicated that neoadjuvant chemo-immunotherapy provided limited local control in stage II–III resectable non-small cell lung cancer (NSCLC).
Estimated Worldwide Variation and Trends in Incidence of Lung Cancer by Histological Subtype in 2022 and Over Time: A Population-Based Study
April 17, 2025
This article presents a comprehensive epidemiological analysis of lung cancer, focusing on subtype-specific patterns worldwide.
Tumour Spread Through Air Spaces Is a Determiner for Treatment of Clinical Stage I Non-Small Cell Lung Cancer: Thoracoscopic Segmentectomy vs Lobectomy
March 13, 2025
This study investigates the impact of tumor spread through air spaces (STAS) on surgical outcomes for early-stage non-small cell lung cancer (NSCLC). In a retrospective analysis of 785 patients, 19.2 percent were found to have STAS-positive NSCLC.
Lung Cancer Screening and USPSTF Recommendations
March 6, 2025
Lung cancer remains the leading cause of cancer-related deaths, and low-dose computed tomography screening can reduce mortality for high-risk individuals.

Pages

Submit Content